The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

por Ahmad, Shamaila Munir, Martinenaite, Evelina, Holmström, Morten, Jørgensen, Mia Aaboe, Met, Özcan, Nastasi, Claudia, Klausen, Uffe, Donia, Marco, Pedersen, Lars Møller, Munksgaard, Lars, Ødum, Niels, Woetmann, Anders, Svane, Inge Marie, Andersen, Mads Hald
Publicado en Oncoimmunology (2017)

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma

por Taskinen, Minna, Louhimo, Riku, Koivula, Satu, Chen, Ping, Rantanen, Ville, Holte, Harald, Delabie, Jan, Karjalainen-Lindsberg, Marja-Liisa, Björkholm, Magnus, Fluge, Øystein, Pedersen, Lars Møller, Fjordén, Karin, Jerkeman, Mats, Eriksson, Mikael, Hautaniemi, Sampsa, Leppä, Sirpa
Publicado 2014

The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial

por Wikkelsoe, Anne Juul, Afshari, Arash, Stensballe, Jakob, Langhoff-Roos, Jens, Albrechtsen, Charlotte, Ekelund, Kim, Hanke, Gabriele, Sharif, Heidi Fosgrau, Mitchell, Anja U, Svare, Jens, Troelstrup, Ane, Pedersen, Lars Møller, Lauenborg, Jeannet, Madsen, Mette Gøttge, Bødker, Birgit, Møller, Ann M
Publicado 2012

Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union

por Jürgen Rehm, Peter Anderson, Jose Angel Arbesu Prieto, Iain Armstrong, Henri-Jean Aubin, Michael Bachmann, Nuria Bastida Bastus, Carlos Brotons, Robyn Burton, Manuel Cardoso, Joan Colom, Daniel Duprez, Gerrit Gmel, Antoni Gual, Ludwig Kraus, Reinhold Kreutz, Helena Liira, Jakob Manthey, Lars Møller, Ľubomír Okruhlica, Michael Roerecke, Emanuele Scafato, Bernd Schulte, Lidia Segura-Garcia, Kevin David Shield, Cristina Sierra, Konstantin Vyshinskiy, Marcin Wojnar, José Zarco
Publicado 2017-09-01